ArticleHarm reduction journal2023

SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya.

Shradha Doshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.